EYPT Competitors & Alternatives
Compare EyePoint, Inc with similar stocks in the same industry
Biotechnology
EYPT
Main Stock$12.21
Tradestie Score
52
Market Cap
$890.20M
Revenue Growth
1.6%
Analyst Upside
+231.8%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INVA
Innoviva, Inc. Common Stock
|
$20.77
|
$1.15B | 3.5 | 49 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$17.91
|
$1.14B | - | 55 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$10.54
|
$1.14B | - | 54 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$26.94
|
$1.13B | - | 54 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$5.62
|
$1.12B | - | 49 | Compare |
|
NKTR
Nektar Therapeutics
|
$69.27
|
$1.12B | - | 63 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$303.04
|
$1.12B | - | 49 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$8.96
|
$1.09B | - | 48 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$9.98
|
$1.05B | 76.8 | 41 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.36
|
$1.01B | 21.4 | 53 | Compare |
More EYPT Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 3826)
231 stocks in this industry